Leading UK Pharmacies trust Deltera
Protect travellers against Dengue fever with the Qdenga vaccine PGD. Deltera provides the clinical framework to assess suitability—regardless of previous Dengue exposure—and manage the dual-dose schedule.
A Fully Digital Clinical Platform
Integrated Bookings and Payments
Secure & Connected Patient Records
Ditch the paperwork with secure digital records. Deltera automatically shares treatment summaries with the patient’s and sends the required notification to their GP instantly.
Training and Eligibility Requirements
To ensure clinical safety and regulatory compliance, all practitioners using this PGD must meet the following professional standards:
- Professional Registration: Must be a registered healthcare professional (e.g., Pharmacist) with a valid GPhC or PSNI registration and personal professional indemnity insurance.
- Clinical Competency: Practitioners must be self-certified as competent in the specific clinical area covered by this PGD and stay up to date with relevant national guidelines (e.g., The Green Book or NICE clinical summaries).
- Mandatory Training: Current certification in Basic Life Support (BLS) and the management of anaphylaxis is required for all injectable services.
- PGD Authorisation: The practitioner must have read and signed the PGD document within the Deltera Clinical Dashboard, with the authorisation counter-signed by the designated organisational lead or Superintendent.
- Premises Standards: Services must be conducted in a private consultation room that meets national standards for patient confidentiality and clinical safety.
Speak to the clinicians behind the platform
We understand the complexities of PGDs and clinical governance in the UK. Schedule a meeting with our team to see how we can help you navigate the changing landscape of community pharmacy.
Access related PGDs
FAQs
Travellers visiting endemic areas, especially those with a history of previous infection. Deltera’s pre-screening logic assesses risk factors to guide the pharmacist’s recommendation.
No. Unlike previous vaccines, Qdenga can be used regardless of prior exposure. Deltera’s digital pre-screen handles this nuance to ensure the consultation is efficient.
It is a two-dose course, three months apart. Deltera sends automated notifications to the patient to ensure they return for their second dose, protecting your pharmacy’s revenue.
Once administered, the treatment summary is instantly available in the patient’s branded portal, providing them with a secure record of their Dengue protection.
Still have questions?
Our team are here to support you.
Discover Deltera Practice Management
Deltera Practice Management digitalises your private pharmacy services, providing the complete pharmacy software package to offer a full range of Patient Group Directions (PGDs). Gain the oversight and efficiency you need to thrive.
